| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 222 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 217 |
| 2 | TACROLIMUS OINTMENT 0.1% | 217 |
| 3 | MYCOPHENOLATE MOFETIL | 185 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 185 |
| 5 | PREDNISONE | 123 |
| 6 | PREDNISOLONE | 45 |
| 7 | PREDNISOLONE ORAL | 45 |
| 8 | PREDNISOLONE ORAL SOLUTION | 45 |
| 9 | FLUDARABINE PHOSPHATE | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 18 | 0.0516 |
| 1 | PAROMOMYCIN SULFATE | 1 | 0.0094 |
| 2 | RILPIVIRINE | 26 | 0.0036 |
| 3 | PRAZIQUANTEL | 1 | 0.0033 |
| 4 | CABOTEGRAVIR | 26 | 0.0032 |
| 5 | MEGNESIUM OXIDE | 1 | 0.0024 |
| 6 | LISOCABTAGENE MARALEUCEL | 2 | 0.0023 |
| 7 | SIROLIMUS | 27 | 0.0020 |
| 8 | TACROLIMUS OINTMENT 0.1% | 217 | 0.0017 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 217 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 226 |
| 1 | Kinase Inhibitor [EPC] | 48 |
| 2 | Alkylating Drug [EPC] | 45 |
| 3 | mTOR Inhibitor Immunosuppressant [EPC] | 39 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 38 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 34 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 34 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 31 |
| 8 | Atypical Antipsychotic [EPC] | 26 |
| 9 | Azole Antifungal [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiprotozoal [EPC] | 18 | 0.0017 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 34 | 0.0016 |
| 2 | Leptin Analog [EPC] | 2 | 0.0016 |
| 3 | Echinocandin Antifungal [EPC] | 10 | 0.0012 |
| 4 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 18 | 0.0008 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 9 | 0.0005 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0004 |
| 8 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Anthelmintic [EPC] | 1 | 0.0003 |